Prognostic value of rest 201Tl-dipyridamole stress 99mTc-sestamibi gated SPECT for predicting patient-based clinical outcomes after bypass surgery in patients with ischemic left ventricular dysfunction

Journal of Nuclear Medicine

Volumn 44, Issue 11, 2003, Pages 1735-1740

  Won, Jun Kang ^a   Dong, Soo Lee ^a   Jin, Chul Paeng ^a   Kim, Ki Bong ^a   Chung, June Key ^a   Myung, Chul Lee ^a  

^a Seoul National University   (South Korea)

Author keywords

Gated SPECT; Patient based approach; Prognosis

Indexed keywords

DIPYRIDAMOLE; TECHNETIUM 99M; DIAGNOSTIC AGENT; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; THALLIUM;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BYPASS SURGERY; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HEART DEATH; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART VOLUME; HOSPITALIZATION; HUMAN; ISCHEMIC HEART DISEASE; MALE; MEDICAL ASSESSMENT; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STATISTICAL ANALYSIS; STATISTICAL MODEL; TREATMENT OUTCOME; CORONARY ARTERY BYPASS GRAFT; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; MORTALITY; ROC CURVE; SCINTISCANNING;

CORONARY ARTERY BYPASS; DIPYRIDAMOLE; HUMANS; LOGISTIC MODELS; MYOCARDIAL ISCHEMIA; PROGNOSIS; ROC CURVE; TECHNETIUM TC 99M SESTAMIBI; THALLIUM RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0642345876     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Dreyfus GD, Duboc D, Blasco A, et al. Myocardial viability assessment in ischemic cardiomyopathy, benefits of coronary revascularization. Ann Thorac Surg. 1994;57:1402-1407.
2. Marwick TH, Zuchowski C, Lauer MS, Secknus MA, Williams J, Little BW. Functional status and quality of life in patients with heart failure undergoing coronary bypass surgery after assessment of myocardial liability. J Am Coll Cardiol. 1999;33:750-758.
3. Haas F, Haehnel CJ, Picker W, et al Preoperative positron emission tomographic viability assessment and perioperative and postoperative risk in patients with advanced ischemic heart disease. J Am Coll Cardiol 1997;30:1663-1670
4. Marwick TH. The viable myocardium: epidemiology, detection and clinical implications Lancet. 1998;351:815-819.
5. 99mTc-sestamibi. Circulation 1994;89:2552-2561
6. Di Carli MF, Davidson M, Little R, et al Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction Am J Cardiol. 1994;73:527-533.
7. Cigarroa CG, de Filippi CR, Brickner ME, Alvarez LG, Wait MA, Grayburn PA. Dobutamine stress echocardiography identifies hibernating myocardium and predicts recovery of left ventricular function after coronary revascularization. Circulation. 1993;88:430-436.
8. 201Tl single photon emission CT imaging for determination of myocardial viability, mode of therapy and long-term prognosis. Chest. 1999;115:1621-1626.
9. Kitsiou AN, Srinivasan G, Quyyumi AA, Summers RM, Bacharach SL, Dilsizian V. Stress-induced reversible and mild-to-moderate irreversible thallium defects: are they equally accurate for predicting recovery of regional left ventricular function after revascularization? Circulation. 1998;98:501-508.
10. Sciagra R, Santoro GM, Bisi G, Pedenovi P, Fazzini PF, Pupi A. Rest-redistribution thallium-201 SPECT to detect myocardial viability. J Nucl Med. 1998;39:384-390.
11. Berman DS, Hachamovitch R, Kiat H, et al. Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: a basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single photon emission computed tomography. J Am Coll Cardiol. 1995;26:639-647
12. 99mTc-Tetrofosmin SPECT for prediction of functional recovery defined by MRI in patients with severe left ventricular dysfunction: additional value of gated SPECT. J Nucl Med. 1999;40:1824-1831.
13. Depuey EG, Ghesani M, Schwartz M, Friedman M, Nichols K, Salensky H. Comparative performance of gated perfusion SPECT wall thickening, delayed thallium uptake and F-18 fluorodeoxyglucose SPECT in detecting myocardial viability. J Nucl Cardiol. 1999;6:418-428
14. Mabuchi M, Kubo N, Morita K, et al Prediction of functional recovery after coronary bypass surgery using quantitative gated myocardial perfusion SPECT Nucl Med Commun 2003;24:625-631.
15. Maruyama A, Hasegawa S, Paul AK, et al. Myocardial viability assessment with gated SPECT Tc-99m tetrofosmin % wall thickening: comparison with F-18 FDG-PET. Ann Nucl Med 2002;16:25-32
16. Germano G, Erel J, Lewin H, Kavanagh PB, Berman DS. Automatic quantification of regional wall motion and thickening from gated technetium-99m sestamibi myocardial perfusion single photon emission computed tomography J Am Coll Cardiol. 1997;30:1360-1367.
17. 99mTc-sestamibi myocardial SPECT. J Nucl Med. 2001;42:695-700.
18. 201Tl imaging in detection of myocardial viability and prediction of improvement in left ventricular dysfunction after coronary bypass surgery in patients with severely depressed left ventricular function. Circulation 1993;87:1630-1641
19. Sciagra R, Leoncini M, Cannizzaro G, Marcucci G, Pupi A, Bisi G. Predicting revascularization outcome in patients with coronary artery disease and left ventricular dysfunction (data from the SEMINATOR study). Am J Cardiol. 2002;89:1369-1373.
20. Cuocolo A, Petretta M, Nicolai E, et al. Successful coronary revascularization improves prognosis in patients with previous myocardial infarction and evidence of viable myocardium at thallium-201 imaging. Eur J Nucl Med. 1998;25:60-68
21. Bax JJ, Poldermans D, Elhendy A, et al. Improvement of left ventricular ejection fraction, heart failure symptoms and prognosis after revascularization in patients with chronic coronary artery disease and viable myocardium detected by dobutamine stress echocardiography J Am Coll Cardiol. 1999;34:163-169.
22. Sharir T, Germano G, Kavanagh PB, et al. Incremental prognostic value of post-stress left ventricular ejection fraction and volume by gated myocardial perfusion single photon emission computed tomography. Circulation. 1999;100:1035-1042.
23. Hamer AW, Takayama M, Abraham KA, et al. End-systolic volume and long-term survival after coronary artery bypass graft surgery in patients with impaired left ventricular function Circulation 1994;90:2899-2904.
24. Sharir T, Berman DS, Waechter PB, et al. Quantitative analysis of regional motion and thickening by gated myocardial perfusion SPECT: normal heterogeneity and criteria for abnormality. J Nucl Med. 2001;42:1630-1638.
25. Germano G, Kavanagh PB, Kavanagh JT, et al. Repeatability of automatic left ventricular cavity volume measurements from myocardial perfusion SPECT. J Nucl Cardiol. 1998;5:477-483.
26. 99mTc-MIBI SPECT and quantitative software. Nucl Med Commun. 2000;21:1127-1134.
27. Vallejo E, Dione DP, Brum WL, et al. Reproducibility and accuracy of gated SPECT for determination of left ventricular volumes and ejection fraction experimental validation using MRI. J Nucl Med. 2000;41:874-882.
28. Bax JJ, Visser FC, Poldermans D, et al. Relationship between preoperative viability and postoperative improvement in left ventricular ejection fraction and heart failure symptoms J Nucl Med. 2001;42:79-86.
29. Samady H, Elefteriades JA, Abbott BG, Mattera JA, McPherson CA, Wackers FJ. Failure to improve left ventricular function after coronary revascularization for ischemic cardiomyopathy is not associated with worse outcome. Circulation. 1999;100:1298-1304.
30. Yun JH, Block M, Botvinick EH. Unique contraction pattern in patients after coronary bypass surgery by gated SPECT myocardial perfusion imaging Clin Nucl Med. 2003;28:18-24.
31. 99mTc-MIBI SPECT for functional assessment of patients after coronary artery bypass surgery: comparison of wall thickening and wall motion analysis. J Nucl Med. 2002;43:589-595.